Pharma Journalist -

Merck, known as MSD outside the United States and Canada, announced the U.S. Food and Drug Administration (FDA) has accepted for Priority Review a supplemental Biologics License…
Read More...

Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company, announced that it is working with Pfizer to create innovative, cloud-based solutions with the potential to improve how new…
Read More...

Premas Biotech announced that its joint venture Oravax will initiate testing of their oral virus-like particle (VLP) vaccine candidate against Omicron variant of SARS-CoV 2 virus…
Read More...

Astellas Pharma Inc. and Dyno Therapeutics, Inc. announced an option and license agreement was signed on November 23 to develop next-generation adeno-associated virus (AAV) vectors for…
Read More...

AbbVie announced it has submitted an application to the European Medicines Agency (EMA) seeking approval for risankizumab (SKYRIZI, 600 mg intravenous (IV) induction and 360 mg…
Read More...

AstraZeneca’s supplemental New Drug Application (sNDA) for Lynparza (olaparib) has been accepted and granted Priority Review in the US for the adjuvant treatment of patients with…
Read More...

UCB, a global biopharmaceutical company, and Chiesi Group, the international research-focused pharmaceutical and healthcare group, are pleased to announce that they have entered into an…
Read More...

BONE THERAPEUTICS, the cell therapy company addressing unmet medical needs in orthopedics and other diseases, and Link Health Pharma Co., Ltd announce the signing of a non-binding term…
Read More...

As we have with previous emerging COVID-19 variants, the U.S. Food and Drug Administration is actively working with our federal partners, international regulators and medical product…
Read More...

First Wave BioPharma, Inc., a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, announced…
Read More...